Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Expanding horizons in overcoming therapeutic resistance in castration-resistant prostate cancer: targeting the androgen receptor-regulated tumor immune microenvironment
When treatment intensification is needed beyond metformin, the choice now increasingly favours GLP-1 receptor agonists like Rybelsus for patients who can tolerate the gastrointestinal side effects and afford the higher price
Many players in BCL-2 family affairs
3 Some studies provide lower numbers, but researchers agree that use of these drugs is climbing
US$ 25.83
US$ 29.88
US$ 24.36
US$ 21.75
US$ 28.75
